BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23353839)

  • 21. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
    Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
    Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.
    Cinatl J; Cinatl J; Vogel JU; Kotchetkov R; Driever PH; Kabickova H; Kornhuber B; Schwabe D; Doerr HW
    Cancer Res; 1998 Jan; 58(2):367-72. PubMed ID: 9443419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
    Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
    Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
    Wedel S; Hudak L; Seibel JM; Juengel E; Oppermann E; Haferkamp A; Blaheta RA
    Prostate; 2011 May; 71(7):722-35. PubMed ID: 20954195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid in the complex therapy of malignant tumors.
    Hrebackova J; Hrabeta J; Eckschlager T
    Curr Drug Targets; 2010 Mar; 11(3):361-79. PubMed ID: 20214599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma.
    Khalil MA; Hraběta J; Groh T; Procházka P; Doktorová H; Eckschlager T
    PLoS One; 2016; 11(9):e0162916. PubMed ID: 27627801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
    Poljaková J; Eckschlager T; Hrabeta J; Hrebacková J; Smutný S; Frei E; Martínek V; Kizek R; Stiborová M
    Biochem Pharmacol; 2009 May; 77(9):1466-79. PubMed ID: 19426684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined valproic acid and celecoxib treatment induced synergistic cytotoxicity and apoptosis in neuroblastoma cells.
    Chen Y; Tsai YH; Tseng SH
    Anticancer Res; 2011 Jun; 31(6):2231-9. PubMed ID: 21737646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood.
    Furchert SE; Lanvers-Kaminsky C; Juürgens H; Jung M; Loidl A; Frühwald MC
    Int J Cancer; 2007 Apr; 120(8):1787-94. PubMed ID: 17230517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells.
    Aouali N; Palissot V; El-Khoury V; Moussay E; Janji B; Pierson S; Brons NH; Kellner L; Bosseler M; Van Moer K; Berchem G
    Br J Haematol; 2009 Dec; 147(5):662-71. PubMed ID: 19793255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Valproic acid induced intracellular GSH-redox imbalance and apoptosis of leukemic cells resistant to dexamethasone and doxorubicin].
    Liu H; Fu RY; Liao QK; Li FY; Zhu YP; Gao J; Mao YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):133-7. PubMed ID: 19292063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
    Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA
    Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways.
    Chen Q; Ouyang DY; Geng M; Xu LH; Zhang YT; Wang FP; He XH
    J Immunotoxicol; 2011; 8(3):210-8. PubMed ID: 21457087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.
    Iwata S; Saito T; Ito Y; Kamakura M; Gotoh K; Kawada J; Nishiyama Y; Kimura H
    Cancer Sci; 2012 Feb; 103(2):375-81. PubMed ID: 22017376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.
    Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD
    Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory effect of valproic acid on cell cycle of Kasumi-1 cell line and its mechanism].
    Zhao L; Zhang ZH; Zhu CM
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):802-5. PubMed ID: 19176032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma.
    Kaiser M; Zavrski I; Sterz J; Jakob C; Fleissner C; Kloetzel PM; Sezer O; Heider U
    Haematologica; 2006 Feb; 91(2):248-51. PubMed ID: 16461312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines.
    Das CM; Zage PE; Taylor P; Aguilera D; Wolff JE; Lee D; Gopalakrishnan V
    Eur J Cancer; 2010 Oct; 46(15):2771-80. PubMed ID: 20886683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis.
    Stamatopoulos B; Meuleman N; De Bruyn C; Mineur P; Martiat P; Bron D; Lagneaux L
    Leukemia; 2009 Dec; 23(12):2281-9. PubMed ID: 19710697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.